Corporate ActionJun 1, 2026, 07:02 AM
IN8bio Establishes New ATM Offering with JonesTrading
AI Summary
IN8bio, Inc. has entered into a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, establishing an at-the-market (ATM) offering program. This agreement allows the company to issue and sell shares of its common stock through JonesTrading, which will earn a 3.0% commission on gross sales proceeds. Concurrently, IN8bio terminated its previous Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co. without incurring any penalties.
Key Highlights
- IN8bio entered a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC.
- The agreement establishes an at-the-market (ATM) offering program for common stock.
- JonesTrading will receive a 3.0% commission on gross sales proceeds.
- The company terminated its prior ATM sales agreement with Cantor Fitzgerald & Co.
- No termination penalties were incurred from ending the Cantor Fitzgerald agreement.
Price Impact
More from INAB